AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Top 28%
#1471 out of 5327 analysts
Average Return
+6.92%
Win Rate
64%18 out of 28
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Meiragtx Holdings PLCMGTX | +49.08% | $8.19 | $12.21 | 2025-11-14 - 2026-07-20 | Buy |
Eyepoint IncEYPT | +46.20% | $8.81 | $12.88 | 2025-06-17 - 2026-06-16 | Buy |
Viridian Therapeutics IncVRDN | +32.95% | $13.96 | $18.56 | 2026-04-07 - 2026-07-20 | Buy |
Meiragtx Holdings PLCMGTX | +29.89% | $9.40 | $12.21 | 2026-05-15 - 2026-07-20 | Buy |
4d Molecular Therapeutics IncFDMT | +23.50% | $8.98 | $11.09 | 2026-03-19 - 2026-07-20 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Meiragtx Holdings PLCMGTX | 4 | Buy | $26.00 | +112.94% | Maintains | 14 days ago |
United Therapeutics CorpUTHR | 5 | Buy | $704.00 | +33.00% | Maintains | 15 days ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Buy | $141.00 | +34.80% | Maintains | 15 days ago |
Mirum Pharmaceuticals IncMIRM | 2 | Buy | $148.00 | +26.91% | Maintains | 15 days ago |
Viridian Therapeutics IncVRDN | 6 | Buy | $35.00 | +88.58% | Maintains | 22 days ago |
Eyepoint IncEYPT | 3 | Buy | $37.00 | +192.26% | Maintains | 2 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $30.00 | +244.43% | Reiterates | 3 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Buy | $35.00 | +215.60% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $21.00 | -48.82% | Maintains | 5 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | -8.26% | Maintains | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.